secwatch / observer
8-K filed October 25, 2022, 7:59 PM ET ticker ZTS CIK 0001555280
leadership confidence high sentiment neutral materiality 0.50

Zoetis appoints Glenn David as EVP of U.S. Ops, Diagnostics, BioDevices; Jamie Brannan to International Ops

Zoetis Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Wafaa Mamilli

Chief Digital and Technology Officer
ZTS · Zoetis Inc.
Effective
2022-11-01
Filed
October 25, 2022, 7:59 PM ET
Wafaa Mamilli, the Company’s Chief Digital and Technology Officer, will also assume oversight of China, Brazil and Precision Animal Health, effective November 1, 2022.
Role change

Jamie Brannan

Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ)
ZTS · Zoetis Inc.
Effective
2022-11-01
Filed
October 25, 2022, 7:59 PM ET
the Company has appointed Jamie Brannan, who currently serves as the Company’s President, International Operations, as the Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ), effective November 1, 2022.
Role change

Glenn David

Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices
ZTS · Zoetis Inc.
Effective
2022-11-01
Filed
October 25, 2022, 7:59 PM ET
Zoetis Inc. (the “Company”) appointed Glenn David as the Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective November 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wafaa Mamilli changed role as Chief Digital and Technology Officer at Zoetis Inc..

Action
assume oversight
Role
Chief Digital and Technology Officer
Exact text from the filing
Wafaa Mamilli, the Company’s Chief Digital and Technology Officer, will also assume oversight of China, Brazil and Precision Animal Health, effective November 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jamie Brannan was appointed as Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ) at Zoetis Inc..

Action
appointed
Role
Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ)
Exact text from the filing
the Company has appointed Jamie Brannan, who currently serves as the Company’s President, International Operations, as the Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ), effective November 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Glenn David was appointed as Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc..

Action
appointed
Role
Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices
Exact text from the filing
Zoetis Inc. (the “Company”) appointed Glenn David as the Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective November 1, 2022.
View on SEC.gov

Zoetis Inc. filing history →

Source: SEC EDGAR
accession 0001555280-22-000266
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.